AstraZeneca’s Tagrisso shows eight-year landmark survival in early-stage EGFR-mutated lung cancer
The results from a global phase 3 trial show the longest survival data ever reported in this setting
Read More
Section: Research
AstraZeneca shares phase 3 results for Imfinzi plus Imdelltra in extensive-stage small cell lung cancer
Around 195,000 people globally will be treated for this form of lung cancer in 2026
Read More
Novartis announces trial results for remibrutinib in relapsing multiple sclerosis
MS affects nearly three million people worldwide and has three main types
Read More
BriaCell advances personalised skin cancer immunotherapy vaccine candidate
Around 112,000 new cases of skin cancer will be diagnosed in the US in 2026
Read More
‘Switchable’ smart gel may pave the way for next-gen drug delivery and sensing tech
Researchers have created the first multi-responsive gel built from ‘foldamers’ – a discovery that could lead to smart sensors, switchable catalysts and more
Read More